Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na+,K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats

Diabetologia

Volumn 42, Issue 6, 1999, Pages 743-747

  Wada, R ^a   Sugo, M ^a   Nakano, M ^b   Yagihashi, S ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b MITSUBISHI GAS CHEMICAL COMPANY INC   (Japan)

Author keywords

(Na+,K+) ATPase activity; Aminoguanidine; Experimental diabetic neuropathy; Insulin; Nerve conduction velocity; Thrombomodulin Introduction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINOGUANIDINE; INSULIN; THROMBOMODULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; ENDOTHELIUM INJURY; ENZYME ACTIVITY; GLYCATION; INSULIN TREATMENT; MALE; NERVE CONDUCTION; NERVE FUNCTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; TIBIAL NERVE;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUANIDINES; MALE; NA(+)-K(+)-EXCHANGING ATPASE; NEURAL CONDUCTION; RATS; RATS, WISTAR; STREPTOZOCIN; THROMBOMODULIN;

EID: 0033065148     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051223     Document Type: Article

References (30)

1. 1. Bucala R, Cerami A, Vlassara H (1995) Advanced glycosylation end products in diabetic complications. Diabetes Rev 3: 258-268
2. 2. Dickamer K (1996) Breaking the curse of the AGEs. Nature 382: 211-212
3. 3. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA (1991) Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88: 6107-6111
4. 4. Cameron NE, Cotter MA, Dines K, Love A (1992) Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35: 946-950
5. 5. Yagihashi S, Kamijo M, Baba M, Yagihashi N, Nagai K (1992) Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41: 47-52
6. 6. Sugimoto K, Yagihashi S (1997) Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvas Res 53: 105-112
7. 7. Esmon CT, Owen WG (1981) Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78: 2249-2252
8. 8. Maruyama I, Bell CE, Majerus PW (1985)Thrombomodulin is found on endothelium of arteries, veins, capillaries and lymphatics and syncytiotrophoblast of human placenta. J Cell Biol 101: 363-371
9. 9. Takano S, Kimura S, Ohdama S, Aoki N (1990) Plasma thrombomodulin in health and diseases. Blood 76: 2024-2029
10. 10. Yoshida M, Kozaki M, Ioya N, Kaji N, Tamaki T, Hiraishi S (1990) Plasma thrombomodulin levels as an indicator of vascular injury caused by cyclosporine nephropathy. Transplantation 50: 1066-1069
11. 11. Iwashima Y, Sato T, Watanabe K et al. (1990) Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 39: 983-988
12. 12. Tanaka A, Ishii H, Hiraishi S, Kazama M, Maezawa H (1991) Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem 37: 269-272
13. 13. Kimura FJ (1983) F-wave determination in nerve conduction studies. In: Desmedt J (ed) Motor control mechanisms in health and disease. Raven Press, New York, pp 961-975
14. 14. Greene DA, Lattimer SA (1983) Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72: 1058-1063
15. 15. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y (1986) The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 125: 431-435
16. 16. Vlassara H, Brownlee M, Cerami A (1983) Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 32: 670-674
17. 17. Cullum NA, Mahon J, Stringer K, McLean WG (1991) Glycation of rat sciatic nerve tubulin in experimental diabetes mellitus. Diabetologia 34: 387-389
18. 18. Ryle C, Donaghy M (1995) Non-enzymatic glycation of peripheral nerve proteins in human diabetics. J Neurol Sci 129: 62-68
19. 19. Charonis AS, Tsilibary EC (1992) Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes 41: 49-51
20. 20. Sugimoto K, Nishizawa Y, Horiuchi S, Yagihashi S (1997) Localization in human diabetic peripheral nerve of ne-carboxymethyl-lysine protein adducts, one of advanced glycation end-products. Diabetologia 40: 1380-1387
21. 21. Greene DA, Lattimer SA, Sima AA (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599-606
22. 2. J Clin Invest 96: 733-740
23. +-ATPase activity in SH-SY5Y human neuroblastoma cells. Diabetologia 41: 1451-1458
24. 24. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438
25. 25. Yamagishi S, Fujimori H, Yonekura H, Yamamoto Y, Yamamoto H (1998) Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia 41: 1425-1441
26. 26. Cameron NE, Cotter MA (1996) Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition. Metabolism 45: 1147-1152
27. 27. Tesfamariam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326
28. 28. Cotter MA, Love A, Watt MJ, Cameron NE, Dines KC (1995) Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38: 1285-1294
29. 29. Cameron NE, Cotter MA (1994) The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 10: 189-224
30. 30. Yagihashi S (1995) Pathology and pathogenetic mechanisms of diabetic neuropathy. Diabetes Metab Rev 11: 193-225